The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2021 | Future directions & unmet needs in HCC
Philippe Merle, MD, PhD, Croix-Rousse Hospital, Lyon, France, discusses the future directions in the treatment of hepatocellular carcinoma, including safe and efficacious therapies, combinatorial approaches and personalized medicine. Prof. Merle also highlights biomarkers as an urgent area of unmet need in patients with HCC. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
